Cardiovascular Risk Prediction in Patients With Human Immunodeficiency Virus

Affiliations

¹ Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
² HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, University College London Royal Free Campus, London, England.
³ Metabolic Clinic, Infectious and Tropical Diseases Unit, Department of Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Free article

Comment

Paolo Raggi et al. JAMA Cardiol. 2017.

Free article

. 2017 Sep 1;2(9):1048.

doi: 10.1001/jamacardio.2017.0667.

¹ Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
² HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, University College London Royal Free Campus, London, England.
³ Metabolic Clinic, Infectious and Tropical Diseases Unit, Department of Medicine, University of Modena and Reggio Emilia, Modena, Italy.

No abstract available

Comment in

Cardiovascular Risk Prediction in Patients With Human Immunodeficiency Virus-Reply.
Feinstein MJ, Delaney JA, Crane HM. Feinstein MJ, et al. JAMA Cardiol. 2017 Sep 1;2(9):1048-1049. doi: 10.1001/jamacardio.2017.0649. JAMA Cardiol. 2017. PMID: 28467528 Free PMC article. No abstract available.

Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.
Feinstein MJ, Nance RM, Drozd DR, Ning H, Delaney JA, Heckbert SR, Budoff MJ, Mathews WC, Kitahata MM, Saag MS, Eron JJ, Moore RD, Achenbach CJ, Lloyd-Jones DM, Crane HM. Feinstein MJ, et al. JAMA Cardiol. 2017 Feb 1;2(2):155-162. doi: 10.1001/jamacardio.2016.4494. JAMA Cardiol. 2017. PMID: 28002550 Free PMC article.